Advertisement

Age Related Circadian Responsiveness of MAO Inhibitors

  • E. Radha
Part of the Advances in experimental medicine and biology book series (AEMB, volume 108)

Abstract

We are becoming increasingly aware of the concept of a biological clock which regulates development and aging. This clock, or clocks, appears to be comprised of a constellation of rhythmic processes occurring throughout the organism in all tissues, organs and systems (Timiras, 1972). As illustrated by Berger (1975), these clocks may govern sleep and wakefulness patterns both phylogenetically and ontogenetically, and repeated inversions of the 12 hour light/dark cycles may dampen such rhythms and result in an actual shortening of life span.

Keywords

Monoamine Oxidase Inhibit Monoamine Oxidase Circadian Variation Amine Oxidase Circadian Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aslan, A. A new method for prophylaxis and treatment of aging with novacaine. Therapiewoche 7: 14, 1956.Google Scholar
  2. Bennet, D.S. and Giarman, N.J. Schedule of appearance of 5-hydroxy-tryptamine (serotonin) and associated enzymes in developing rat brain. J. Neurochem. 12: 911–918, 1965.CrossRefGoogle Scholar
  3. Berger, R.J. Bioenergetic functions of sleep and activity rhythms and their possible relevance to aging. Fed. Proc. 34: 97–102, 1975.PubMedGoogle Scholar
  4. Bowers, M.B. and Gerbode, F.A. Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature 219: 1256–1257, 1968.PubMedCrossRefGoogle Scholar
  5. Cohen, S. Gerovital H3 in the treatment of the depressed aging patient. Presented at 20th Annual Meeting of Academy of Psychosomatic Medicine, 1973.Google Scholar
  6. Finch, C.E. Monoamine metabolism in aging male mouse. In: Development and Aging in the Nervous System, M. Rockstein, ed. Academic Press, New York, pp 199–218, 1973.CrossRefGoogle Scholar
  7. Gey, K.F., Burkard, W.P. and Pletscher, A. Variation of norepinephrine metabolism of the rat heart with age. Gerontologia 11: 1–11, 1965.PubMedCrossRefGoogle Scholar
  8. Halberg, F. Chronobiology in 1975. Chronobiologia 3: 1–11, 1976.PubMedGoogle Scholar
  9. Halberg, F. and Stephens, A.N. Susceptibility to ouabain and physiologic circadian periodicity. Proc. Minn. Acad. Sci. 27: 139–143, 1959.Google Scholar
  10. Haus, E. and Halberg, F. 24-hour rhythm in susceptibility of C mice to a toxic dose of ethanol. J. Appl. Physiol. 14: 878–880, 1959.PubMedGoogle Scholar
  11. Hortia, A. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition. Biochem. Pharmacol. 17: 2091–2096, 1968.CrossRefGoogle Scholar
  12. Ho-Van-Hap, A., Barbineau, L.M. and Berlinguet, L. Hormonal action of monoamine oxidase activity in rats. Can. J. Biochem. 45: 355–362, 1967.PubMedCrossRefGoogle Scholar
  13. Hrachovec, J.P. Inhibitory effect of gerovital H3 on rat brain monoamine oxidase. Fed. Proc. 31: 604, 1972a.Google Scholar
  14. Hrachovec, J.P. Inhibitory effect of gerovital H3 on monoamine oxidase of rat brain, liver and heart. Physiologist 15: Abstract No. 3, 1972b.Google Scholar
  15. Hrachovec, J.P. Inhibitory effect of gerovital H3 and procaine on monoamine oxidase in rat brain, liver, heart and platelets. Proc. 26th Ann. Meeting Gerontol. Soc., Miami Beach, p 62, 1973.Google Scholar
  16. Jarvik, L.F. and Milne, J.F. In: Aging, Vol. 2, S. Gershon and A. Raskin, eds. Raven Press, New York, 1975.Google Scholar
  17. Layne, E. Spectrophotometric and turbidimetric method for measuring proteins. In: Methods in Enzymology, Vol. 3, S.P. Colowick and N.O. Kaplan, eds. Academic Press, New York, pp 447–454, 1957.CrossRefGoogle Scholar
  18. MacFarlane, M.D. Aging, monoamines and monoamine oxidase blood levels. Lancet 2: 337–338, 1972.PubMedCrossRefGoogle Scholar
  19. MacFarlane, M.D. Possible rationale for procaine (Gerovital H3) therapy in geriatric inhibition of monoamine oxidase. J. Amer. Ger. Soc. 21: 414–418, 1973.Google Scholar
  20. MacFarlane, M.D. Procaine HC1 (Gerovital H3): A weak, reversible, fully competitive inhibitor of monoamine oxidase. In: Biology of Aging and Development, G.J. Thorbecke, ed. MacMillan Co., New York, p 213, 1975.CrossRefGoogle Scholar
  21. MacFarlane, M.D. and Besbris, J.H. Procaine (Gerovital H3) therapy: Mechanism of inhibition of monoamine oxidase. J. Amer. Ger. Soc. 22: 365–371, 1974.Google Scholar
  22. Nachmias, J.T. Amine oxidase and 5-hydroxytryptamine in developing rat brain. J. Neurochem. 6: 99–104, 1960.PubMedCrossRefGoogle Scholar
  23. Prange, A.J., White, J.E., Lipton, M.A. and Kinkead, A.M. Influence of age on monoamine oxidase and catechol-o-methyltransferase in rat tissue. Life Science 6: 581–586, 1967.CrossRefGoogle Scholar
  24. Reinberg, A. and Halberg, F. Circadian chronopharmacology. Ann. Rev. Pharmacol. 11: 455–492, 1971.PubMedCrossRefGoogle Scholar
  25. Robinson, D.S. Changes in monoamine oxidase and monoamines with human development and aging. In: Biology of Aging and Development, G.J. Thorbecke, ed. MacMillan Co., New York, pp 203–212, 1975.CrossRefGoogle Scholar
  26. Robinson, D.S., Davis, J.M., Neis, A., Ravaris, C.L. and Sylvester, D. Relation of sex and aging to monoamine oxidase activity of human brain, plasma and platelets. Arch. Gen. Psychiat. 24: 536–539, 1971.PubMedCrossRefGoogle Scholar
  27. Robinson, D.S., Neis, A., Davis, J.N., Bunney, W.E., Davis, J.M., Colburn, R.W., Bourne, H.R., Shaw, D.M. and Coopen, A.J. Aging, monoamines and monoamine oxidase. Lancet 1: 290–291, 1972.PubMedCrossRefGoogle Scholar
  28. Scheving, L.E., Mayersbach, H. v. and Pauly, J.E. An overview of chronopharmacology. J. Europ. Toxicol. 7: 203–207, 1974.Google Scholar
  29. Timiras, P.S. Developmental Physiology and Aging. MacMillan Co., New York, 1972.Google Scholar
  30. Weissbach, H., Smith, T.E., Daly, J.W., Wiktop, B. and Odenfriend, S. A rapid spectrophotometric assay of monoamine oxidase based on the rate of disappearance of kyneramine. J. Biol. Chem. 235: 1160–1163, 1960.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • E. Radha
    • 1
  1. 1.Department of ZoologyBangalore UniversityBangaloreIndia

Personalised recommendations